Azipar Injection

A Unique Monocyclic Beta-lactam With Beta-lactamase Stability

• Highly selective against Gram-negative aerobic bacteria
• Low MIC cidal action (less than or equal to 1.6 mg/L)
• Potent against pseudomonal infections
• Choicest alternative to aminoglycoside / 3rd generation cephalosporin resistant cases
• Safe in compromised kidney function scenario
• Urinary Tract Infections (complicated & uncomplicated), including pyelonephritis and cystitis
• Lower Respiratory Tract Infections, including endometritis and pelvic cellulitis ig TID-98% cure'
• Intra-abdominal infections, including peritonitis (95% microbiological curer)
• Skin and Skin-Structure Infections, including those associated with postoperative wounds, ulcers, and burns
• Bone & Joint Infections